Caspofungin and liposomal amphotericin B therapy of experimental murine scedosporiosis

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 12, 2005, Pages 5139-5141

  Bocanegra, Rosie ^a   Najvar, Laura K ^a   Hernandez, Steve ^a   McCarthy, Dora I ^a   Graybill, John R ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMBINATION CHEMOTHERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG MECHANISM; DRUG POTENTIATION; MALE; MONOTHERAPY; MOUSE; MOUSE STRAIN; MYCOSIS; NONHUMAN; PRIORITY JOURNAL; SCEDOSPORIOSIS; SCEDOSPORIUM; SCEDOSPORIUM PROLIFICANS; SURVIVAL;

AMPHOTERICIN B; ANIMALS; ANTIBIOTICS, ANTIFUNGAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; MADUROMYCOSIS; MICE; PEPTIDES, CYCLIC; SCEDOSPORIUM;

EID: 28844465047     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.12.5139-5141.2005     Document Type: Article

References (10)

1. Afeltra, J., E. Dannaoui, J. F. G. M. Meis, J. L. Rodriguez-Tudela, P. E. Verweij, and Eurofung Network. 2002. In vitro synergistic interaction between amphotericin B and pentamidine against Scedosporium prolificans. Antimicrob. Agents Chemother. 46:3323-3326.
2. Alvarez, M., B. L. Ponga, C. Rayon, J. G. Gala, M. C. R. Porto, M. Gonzalez, J. V. Martinez-Suarez, and J. L. Rodriguez-Tudela. 1995. Nosocomial outbreak caused by Scedosporium prolificans (inflatum): four fatal cases in leukemic patients. J. Clin. Microbiol. 33:3290-3295.
3. Berenguer, J., J. L. Rodriguez-Tudela, C. Richard, M. Alvarez, M. A. Sanz, L. Gaztelurrutia, J. Ayats, J. V. Martinez-Suarez, and the Scedosporium prolificans Study Group. 1997. Deep infections caused by Scedosporium prolificans. A report on 16 cases in Spain and a review of the literature. Medicine 76:256-265.
4. Husain, S., B. D. Alexander, P. Munoz, R. K. Avery, S. Houston, T. Pruett, R. Jacobs, E. A. Dominguez, J. G. Tollemar, K. Baumgarten, C. M. Yu, M. M. Wagener, P. Linden, S. Kusne, and N. Singh. 2003. Opportunistic mycclial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycclial fungi. Clin. Infect. Dis. 37:221-229.
5. Husain, S., P. Munoz, G. Forrest, B. D. Alexander, J. Somani, K. Brennan, M. M. Wagener, and N. Singh. 2005. Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal therapy on outcome. Clin. Infect. Dis. 40:89-99.
6. Kurtz, M. B., I. B. Heath, J. Marrinan, S. Dreikorn, J. Onishi, and C. Douglas. 1994. Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-β-D-glucan synthase. Antimicrob. Agents Chemother. 38:1480-1489.
7. Marr, K. A., R. A. Carter, F. Crippa, A. Wald, and L. Corey. 2002. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin. Infect. Dis. 34:909-917.
8. Morrison, V. A., R. J. Haake, and D. J. Weisdorf. 1994. Non-Candida fungal infections after hone marrow transplantation: risk factors and outcome. Am. J. Med. 96:497-503.
9. Perfect, J. R., K. A. Marr, T. J. Walsh, R. N. Greenberg, B. DuPont, J. Torre-Cisneros, G. Just-Nübling, H. T. Schlamm, I. Lutsar, A. Espinel-Ingroff, and E. Johnson. 2003. Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin. Infect. Dis. 36:1122-1131.
10. Spielberger, R. T., B. R. Tegtmeier, M. R. O'Donnell, and J. I. Ito. 1995. Fatal Scedosporium prolificans (S. inflatum) fungemia following allogeneic bone marrow transplantation: report of a case in the United States. Clin. Infect. Dis. 21:1067.